BCL2 and neoplasm: Specifically, the enhanced expression of BCL2 in the context of high Pb levels could indicate a shift towards anti-apoptotic signaling, which not only supports tumor survival but also confers possible resistance to therapies that rely on inducing apoptosis in cancer cells.